Cargando…
Dabigatran overload in acute kidney injury: haemodialysis or idarucizumab? A case report and proposal for a decisional algorithm
Dabigatran overload has been reported in acute kidney injury (AKI), leading to occasional major bleeding. Haemodialysis (HD) was the method used for reversing dabigatran anticoagulant effects before the approval of idarucizumab, which is now indicated for dabigatran reversal in major bleeding or sur...
Autores principales: | Galassi, Andrea, Podda, Gianmarco, Monciino, Paola, Stucchi, Andrea, Del Nero, Alberto, Cozzolino, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173663/ https://www.ncbi.nlm.nih.gov/pubmed/34101772 http://dx.doi.org/10.1093/ckj/sfaa011 |
Ejemplares similares
-
Idarucizumab for the treatment of dabigatran-related nephropathy
por: Alsamarrai, Ammar, et al.
Publicado: (2020) -
Half a century of haemodialysis: two patient journeys
por: Pavlovic, Drasko, et al.
Publicado: (2022) -
Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis
por: Wajih, Zainab, et al.
Publicado: (2021) -
Treatment for severe COVID-19 with a biomimetic sorbent haemoperfusion device in patients on haemodialysis
por: Sandoval, Diego, et al.
Publicado: (2021) -
Central volume shift in acute heart failure revealed by blood volume monitoring during haemodialysis
por: Sumi, Hirofumi, et al.
Publicado: (2021)